BRIEF published on 08/11/2026 at 12:35, 9 days 22 hours ago Immunic, Inc. publie ses résultats financiers et ses mises à jour pour le deuxième trimestre 2026 Vidofludimus Calcium Investissements En Biotechnologie Essais Cliniques Sur La Sclérose En Plaques Nominations De Dirigeants Immunic Financials
BRIEF published on 08/11/2026 at 12:35, 9 days 22 hours ago Immunic, Inc. Reports Q2 2026 Financial Results and Updates Vidofludimus Calcium Leadership Appointments Multiple Sclerosis Trials Biotech Investments Immunic Financials
PRESS RELEASE published on 08/11/2026 at 12:30, 9 days 22 hours ago Immunic, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update Immunic, Inc. reports Q2 2026 financial results and corporate update, with leadership team expansions and Phase 3 trials progress for vidofludimus calcium in MS Financial Results Corporate Update Immunic Inc. Vidofludimus Calcium Q2 2026
BRIEF published on 08/10/2026 at 22:10, 10 days 13 hours ago Elena Ridloff rejoint le conseil d'administration d'Immunic en tant que directrice stratégique Vidofludimus Calcium Leadership En Biotechnologie Conseil D'immunisation Elena Ridloff Phase 3 ENSURE
BRIEF published on 08/10/2026 at 22:10, 10 days 13 hours ago Elena Ridloff Joins Immunic's Board as Strategic Director Vidofludimus Calcium Immunic Board Elena Ridloff Biotechnology Leadership Phase 3 ENSURE
PRESS RELEASE published on 08/10/2026 at 22:05, 10 days 13 hours ago Immunic Appoints Elena Ridloff to Board of Directors Immunic appoints Elena Ridloff, a financial and capital markets expert, to its Board of Directors, enhancing leadership as the company approaches pivotal phase 3 ENSURE Readout for Multiple Sclerosis treatments Board Of Directors Immunic Elena Ridloff MS Treatments ENSURE Readout
BRIEF published on 07/09/2026 at 12:35, 1 month 11 days ago Immunic annonce sa participation aux conférences investisseurs de juillet Biotechnologie Immunic Inc. Thérapies Orales Conférences D'investisseurs Maladies Neurologiques
BRIEF published on 07/09/2026 at 12:35, 1 month 11 days ago Immunic Announces Participation in July Investor Conferences Biotechnology Investor Conferences Immunic Inc. Oral Therapies Neurologic Diseases
PRESS RELEASE published on 07/09/2026 at 12:30, 1 month 11 days ago Immunic to Participate in Investor Conferences in July Immunic, Inc. (Nasdaq: IMUX) to participate in investor conferences in July, presenting at Leerink Partners Therapeutics Forum and B. Riley Securities Mind, Muscle & Vision Summit in Boston Investor Conferences Immunic Inc B. Riley Securities Neurologic Diseases Leerink Partners
BRIEF published on 06/10/2026 at 12:35, 2 months 10 days ago Immunic Engages in Key Conferences this June Oral Therapies Neurologic Diseases Immunic Participation Biotechnology Conferences IMU-856 Presentation
Published on 08/21/2026 at 02:30, 8 hours 56 minutes ago PPX Mining Announces Completion of Debt Settlement
Published on 08/21/2026 at 00:00, 11 hours 26 minutes ago Apex Confirms Favourable Monazite and Bastnaesite Mineralogy at the Rift Rare Earth Project
Published on 08/20/2026 at 23:00, 12 hours 26 minutes ago EQ Inc. Reports Second Quarter 2026 Financial Results
Published on 08/20/2026 at 22:00, 13 hours 26 minutes ago Gold Terra Closes Third and Final Tranche of Its LIFE Offering for Gross Proceeds of Approximately C$10.1 M
Published on 08/20/2026 at 15:30, 19 hours 56 minutes ago Caldwell Announces Promotion of Lindsay Schoen Lane to Partner
Published on 08/21/2026 at 11:00, 26 minutes ago O’KEY GROUP S.A. REPORTS OPERATIONAL AND FINANCIAL RESULTS FOR H1 2026
Published on 08/21/2026 at 10:58, 28 minutes ago EQS-Adhoc: audius SE: Significant Growth of 23% in the First Half of the Year / EBITDA Growth of 16% / Full-Year Outlook
Published on 08/21/2026 at 10:45, 41 minutes ago Industrial Development Bureau of Hengqin Officially Joins ICCA, Exploring Global Resource Channels for the Macao-Hengqin MICE Industry
Published on 08/21/2026 at 09:38, 1 hour 48 minutes ago Gabler Group AG Invites to Earnings Call on H1 2026 Results
Published on 08/18/2026 at 18:00, 2 days 17 hours ago KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 2 days 17 hours ago Mise à disposition du rapport financier annuel 2025-26
Published on 08/18/2026 at 11:15, 3 days ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026
